Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C
Tina Senff, Christopher Menne, Christine Cosmovici, Lia Laura Lewis-Ximenez, Jasneet Aneja, Ruth Broering, Arthur Y. Kim, Astrid M. Westendorf, Ulf Dittmer, Norbert Scherbaum, Georg M. Lauer, Jörg Timm
Tina Senff, Christopher Menne, Christine Cosmovici, Lia Laura Lewis-Ximenez, Jasneet Aneja, Ruth Broering, Arthur Y. Kim, Astrid M. Westendorf, Ulf Dittmer, Norbert Scherbaum, Georg M. Lauer, Jörg Timm
View: Text | PDF
Research Article Immunology Virology

Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C

  • Text
  • PDF
Abstract

Invariant NK T (iNKT) cells are implicated in viral clearance; however, their role in hepatitis C virus (HCV) infection remains controversial. Here, iNKT cells were studied during different stages of HCV infection. iNKT cells from patients with acute HCV infection and people who inject drugs (PWID) with chronic or spontaneously resolved HCV infection were characterized by flow cytometry. In a longitudinal analysis during acute HCV infection, frequencies of activated CD38+ iNKT cells reproducibly declined in spontaneously resolving patients, whereas they were persistently elevated in patients progressing to chronic infection. During the first year of infection, the frequency of activated CD38+ or CD69+ iNKT cells strongly correlated with alanine transaminase levels with particularly pronounced correlations in spontaneously resolving patients. Increased frequencies of activated iNKT cells in chronic HCV infection were confirmed in cross-sectional analyses of PWID with chronic or spontaneously resolved HCV infection; however, no apparent functional differences were observed with various stimulation protocols. Our data suggest that iNKT cells are activated during acute hepatitis C and that activation is sustained in chronic infection. The correlation between the frequency of activated iNKT cells and alanine transaminase may point toward a role of iNKT cells in liver damage.

Authors

Tina Senff, Christopher Menne, Christine Cosmovici, Lia Laura Lewis-Ximenez, Jasneet Aneja, Ruth Broering, Arthur Y. Kim, Astrid M. Westendorf, Ulf Dittmer, Norbert Scherbaum, Georg M. Lauer, Jörg Timm

×

Figure 2

Chronic HCV progression associates with elevated activation of iNKT cells.

Options: View larger image (or click on image) Download as PowerPoint
Chronic HCV progression associates with elevated activation of iNKT cell...
PBMC samples from the acute phase of HCV infection from chronic progressors (n = 15) and resolvers (n = 15) were analyzed by flow cytometry. Samples with less than 20 iNKT cells were excluded from phenotypical analysis. (A and B) Percentage of CD38+ iNKT cells at indicated time points after ETI in resolvers (A) and progressors (B). Each dot represents an individual sample, and each line shows the overall trend for an individual patient over time calculated by linear regression analysis. Patients with more than 2 time points available were included in the analysis. (C and D) Correlation of alanine transaminase (ALT) levels with the frequency of CD38+ iNKT cells in all patients with known ALT level in the first year after ETI that either resolved (C) and progressed to chronic HCV (D). Pearson correlation analysis was used. (E and F) Correlation of ALT levels with the frequency of CD69+ iNKT cells in all patients with known ALT level in the first year after ETI that either resolved (E) or progressed to chronic HCV (F). Pearson correlation analysis was used.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts